Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pebble Accelerator, also known as Tiger Jade Pebble Accelerator, is a venture capital firm based in Hong Kong, dedicated to biomedical innovation. The firm was founded to establish Hong Kong as a global biomedical nexus and currently manages a portfolio of 13 companies. Pebble invests approximately $200,000 in early-stage startups and provides consulting services to facilitate connections with global partners.
Pebble Accelerator invests in early-stage biotech and healthcare startups, typically providing initial investments of around $200,000. The firm also offers consulting services to companies outside its investment scope, helping them connect with investors and partners in China and beyond.
Notable portfolio companies include Opharmic, which develops ultrasound technology for eye treatments; Innovac, focused on personalized mRNA cancer vaccines; and Xandar Kardian, specializing in remote health monitoring with FDA-cleared radar technology. Other companies include Valora, Oncoustics, and Endiatx, each working on innovative solutions in the biomedical field.
To pitch Pebble Accelerator, email your deck to isaac.lui@tigerjadecapital.com.
Pebble Accelerator typically participates in early-stage funding rounds, often leading investments in the companies they back.
The firm is open to follow-on investments, particularly for companies that demonstrate significant progress and alignment with their biomedical focus.
While specific fund size details are not disclosed, Pebble Accelerator focuses on initial investments of approximately $200,000 per startup.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.